PB 65 of 2012

National Health (Efficient Funding of Chemotherapy) Special Arrangement Amendment Instrument 2012 (No. 7)

National Health Act 1953

___________________________________________________________________________

I, STEVE DUNLOP, Assistant Secretary A/g, Pharmaceutical Programs and Support Branch, Pharmaceutical Benefits Division, Department of Health and Ageing, delegate of the Minister for Health, make this instrument under subsections 100(1) and (2) of the National Health Act 1953.

Dated 16 /8/2012

STEVE DUNLOP

Assistant Secretary A/g

Pharmaceutical Benefits Division

Department of Health and Ageing

___________________________________________________________________

1 Name of Instrument

(1)                This Instrument is the National Health (Efficient Funding of Chemotherapy) Special Arrangement Amendment Instrument 2012 (No. 7).

(2)                This Instrument may also be cited as PB 65 of 2012.

2       Commencement

  This Instrument commences on 1 September 2012.

3 Amendments to PB 79 of 2011

  Schedule 1 amends the National Health (Efficient Funding of Chemotherapy) Special Arrangement 2011 (PB 79 of 2011).

Schedule 1 Amendments

[1]     Schedule 1 Part 1, entry for Docetaxel

omit:

substitute:

[2]     Schedule 1 Part 1, entry for Docetaxel in the form Solution concentrate for I.V. infusion 20 mg in 2 mL with manner of administration Injection and brand Docetaxel Sandoz, in the column headed ‘Circumstances’

Insert after C3890:

C3892

[3]     Schedule 1 Part 1, entry for Docetaxel in the form Solution concentrate for I.V. infusion 80 mg in 8 mL with manner of administration Injection and brand Docetaxel Sandoz, in the column headed ‘Circumstances’

Insert after C3890:

C3892

Note

All legislative instruments and compilations are registered on the Federal Register of Legislative Instruments kept under the Legislative Instruments Act 2003.  See http://www.frli.gov.au.